Press Releases Eli Lilly and Company Berne S.E.

Equities

LLY

US5324571083

Delayed Berne S.E. Other stock markets 12:00:02 2024-04-16 pm EDT			5-day change	1st Jan Change
684.5 ^CHF	-1.23%		-2.83%	+40.38%

Jul. 09	Sellers of fake Ozempic to face charges in Austrian court	RE
Jul. 09	Mixed feelings

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Weight loss drug Zepbound outperforms Ozempic in new published study	Jul. 08	AQ
Lilly agrees $3.2b IBD acquisition	Jul. 08	AQ
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024	Jul. 02	AQ
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	Jun. 27	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	Jun. 27	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	Jun. 25	PR
Lilly Declares Third-Quarter 2024 Dividend	Jun. 24	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	Jun. 20	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	Jun. 20	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	Jun. 20	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	Jun. 08	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	Jun. 05	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	Jun. 05	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	Jun. 04	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	Jun. 03	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	May. 31	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	May. 29	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	May. 29	AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference	May. 28	PR
Major manufacturing investment to support API production for tirzepatide	May. 27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT